Sodium Stibogluconate (SSG)

DRUG3 trials

Sponsors

U.S. Army Medical Research and Development Command, Institute of Tropical Medicine, Belgium

Conditions

Cutaneous LeihmaniasisLeishmaniasis

Phase 1

Use of Sodium Stibogluconate as a Treatment for Leishmaniasis

CompletedNCT00657618

U.S. Army Medical Research and Development CommandLeishmaniasis

Start: 2004-10-31End: 2015-04-30Updated: 2020-01-02

Phase 2

Sodium Stibogluconate Treatment of Leishmaniasis

CompletedNCT00662012

U.S. Army Medical Research and Development CommandLeishmaniasis

Start: 2002-06-30End: 2007-12-31Updated: 2021-02-12

Phase 3

Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)

Not yet recruitingNCT07463040

Institute of Tropical Medicine, BelgiumCutaneous Leihmaniasis

Start: 2027-01-01End: 2029-08-31Target: 900Updated: 2026-03-10